Payers must stay informed and agile, leveraging competitive contracts and exploring new therapeutic opportunities to manage costs and provide access to these life-changing therapies
GIP as a therapeutic target in diabetes and obesity: insight from incretin co-agonists
Ingredients: green tea leaf extract of Camellia sinensis standardized to 40% polyphenols, 7% EGCG, L-carnitine tartrate, conjugated linoleic acid, bulking agent - cellulose, carrier - calcium phosphates, anti-caking agents - magnesium salts of fatty acids, silicon dioxide
Lipotropic ingredients such as methionine, inositol, and choline help support normal metabolic processes related to fat utilization and transport, while nutrients like L-carnitine and B vitamins are involved in cellular energy production